Novartis is set to pay the U.S. government $390 million in settlement over charges that the Swiss drug maker engaged in improper business conduct with specialty pharmacies. The federal suit alleged that Novartis gave kickbacks to certain pharmacies to push its drugs to patients.
Novartis Agrees To Pay $390 million In U.S. Settlement Over Illegal Pharmacy Kickbacks
Tech Times - 22 Nov 2015 11:28
Novartis is set to pay the U.S. government $390 million in settlement over charges that the Swiss drug maker engaged in improper business conduct with specialty pharmacies. The federal suit alleged that Novartis gave kickbacks to certain pharmacies to push its drugs to patients.
Share this Article
Recommended